06 December 2024
The government allocated over 5 billion rubles for preferential lending to buy priority imported products. Launched in late 2022, this initiative offers affordable financing for essential foreign products. The list includes drugs containing insulin, antibiotics, various types of medical devices and other medical goods.
Funds will be distributed to credit institutions and VEB.RF to offset losses from issuing preferential loans to importers. This measure supports existing loans of about 140 billion rubles, ensuring favorable terms for borrowers.
The total amount of state support for this program in 2024 will amount to 14.6 billion rubles from the federal budget. The main goal of the funding is to stimulate the import of priority goods through the mechanism of affordable lending to enterprises. The implementation of the program and the targeted use of budget funds will be monitored by the Ministry of Industry and Trade, which is ordered to submit a report on the results to the government by early February 2025.
PrintNovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
03 November 2024
The State Duma may oblige marketplaces to guarantee the quality of dietary supplements
16 December 2024
The Center for Microfluidic Technologies has opened in Moscow
16 December 2024
Industry M&A volume declined 8% this year compared to '23: PwC
13 December 2024
The Russian Ministry of Health has created a Code of Ethics for AI in healthcare
13 December 2024